Revenio Group Corporation Stock Exchange Release, November 25, 2014 at 11.00 a.m. REVENIO GROUP'S FINANCIAL REPORTING IN 2015 During 2015, Revenio Group Corporation will publish the following financial reports: - Financial Statements bulletin in regard to 2014 on Thursday, February 12, 2015 - Interim Report 1-3/2015 on Friday, April 24, 2015 - Interim Report 1-6/2015 on Monday, August 10, 2015 - Interim Report 1-9/2015 on Tuesday, October 27, 2015 The Annual General Meeting is planned to be hold on Thursday, March 19, 2015. Annual Report for 2014 will be published on the week 9. Revenio Group Corporation Olli-Pekka Salovaara President & CEO For additional information, please contact President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi www.revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy and Oscare Medical Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its operating margin standing at 21.7%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1873724]